DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,055,418 | -0.1% | 4,254 | -3.3% | 0.07% | 0.0% |
| Q2 2023 | $1,056,676 | +60.3% | 4,400 | +68.3% | 0.07% | +55.3% |
| Q1 2023 | $659,301 | -6.0% | 2,615 | -1.1% | 0.05% | -16.1% |
| Q4 2022 | $701,699 | +7.5% | 2,643 | +2.6% | 0.06% | -6.7% |
| Q3 2022 | $653,000 | +30.9% | 2,576 | +30.7% | 0.06% | +66.7% |
| Q2 2022 | $499,000 | -36.5% | 1,971 | -26.5% | 0.04% | -35.7% |
| Q1 2022 | $786,000 | -9.1% | 2,680 | +2.0% | 0.06% | +1.8% |
| Q4 2021 | $865,000 | -9.1% | 2,627 | -16.0% | 0.06% | -15.4% |
| Q3 2021 | $952,000 | +11.7% | 3,127 | -1.6% | 0.06% | +16.1% |
| Q2 2021 | $852,000 | +16.2% | 3,177 | -2.5% | 0.06% | +14.3% |
| Q1 2021 | $733,000 | -18.6% | 3,258 | -19.6% | 0.05% | -36.4% |
| Q4 2020 | $900,000 | -3.8% | 4,052 | -6.8% | 0.08% | -19.8% |
| Q3 2020 | $936,000 | +18.3% | 4,346 | -2.8% | 0.10% | +12.9% |
| Q2 2020 | $791,000 | +44.9% | 4,469 | +13.2% | 0.08% | +30.8% |
| Q1 2020 | $546,000 | -0.9% | 3,947 | +9.9% | 0.06% | +30.0% |
| Q4 2019 | $551,000 | -0.4% | 3,591 | -6.3% | 0.05% | -2.0% |
| Q3 2019 | $553,000 | -4.2% | 3,832 | -5.1% | 0.05% | 0.0% |
| Q2 2019 | $577,000 | -51.8% | 4,036 | -55.5% | 0.05% | -51.9% |
| Q1 2019 | $1,197,000 | +23.0% | 9,065 | -3.9% | 0.11% | +6.0% |
| Q4 2018 | $973,000 | -18.9% | 9,428 | -14.6% | 0.10% | -18.0% |
| Q3 2018 | $1,200,000 | +8.5% | 11,044 | -1.4% | 0.12% | +0.8% |
| Q2 2018 | $1,106,000 | +4.8% | 11,206 | +4.0% | 0.12% | -4.0% |
| Q1 2018 | $1,055,000 | +167.8% | 10,773 | +154.1% | 0.13% | +162.5% |
| Q4 2017 | $394,000 | +16.9% | 4,239 | +7.9% | 0.05% | +9.1% |
| Q3 2017 | $337,000 | +72.8% | 3,929 | +70.7% | 0.04% | +57.1% |
| Q2 2017 | $195,000 | -64.9% | 2,302 | -64.5% | 0.03% | -60.0% |
| Q1 2017 | $555,000 | -40.3% | 6,493 | -45.7% | 0.07% | -45.3% |
| Q4 2016 | $929,000 | +10.2% | 11,951 | +11.2% | 0.13% | +13.3% |
| Q3 2016 | $843,000 | -11.5% | 10,744 | +13.9% | 0.11% | -14.4% |
| Q2 2016 | $953,000 | +92.5% | 9,434 | +80.6% | 0.13% | +33.3% |
| Q1 2016 | $495,000 | +51.8% | 5,223 | +49.2% | 0.10% | +45.6% |
| Q4 2015 | $326,000 | +90.6% | 3,501 | +75.0% | 0.07% | +83.8% |
| Q3 2015 | $171,000 | -17.8% | 2,001 | -17.6% | 0.04% | -14.0% |
| Q2 2015 | $208,000 | +0.5% | 2,427 | -0.0% | 0.04% | -2.3% |
| Q1 2015 | $207,000 | -0.5% | 2,428 | 0.0% | 0.04% | -8.3% |
| Q4 2014 | $208,000 | +12.4% | 2,428 | 0.0% | 0.05% | 0.0% |
| Q3 2014 | $185,000 | +17.8% | 2,428 | +21.3% | 0.05% | +17.1% |
| Q2 2014 | $157,000 | +118.1% | 2,001 | +110.6% | 0.04% | +95.2% |
| Q1 2014 | $72,000 | -6.5% | 950 | -5.1% | 0.02% | -4.5% |
| Q4 2013 | $77,000 | +126.5% | 1,001 | +106.8% | 0.02% | +120.0% |
| Q3 2013 | $34,000 | +13.3% | 484 | +3.4% | 0.01% | +25.0% |
| Q2 2013 | $30,000 | – | 468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |